A leading water treatment company in Norfolk has been acquired by a rapidly expanding Scottish firm.

Aquazone, based in Great Yarmouth, has been a supplier of products servicing the UK's water and utilities market since 1995. 

But now RSE, a specialist water treatment and clean energy solutions provider based in Inverness, has acquired a 75pc stake in the Norfolk firm. 

Aquazone's current owners Alan Williams and Chad Ellis will continue to lead the business as part of RSE.

Aquazone recently took on several apprentices who lost their jobs and were at risk of losing their apprenticeships entirely when Specialised Management Services (SMS)-Alderley, in Gorleston, went into administration.

READ MORE: Apprentices who lost jobs when Norfolk firm went bust get new lifeline

Aquazone, in Great YarmouthAquazone, in Great Yarmouth (Image: Supplied) “We have joined the RSE family at an amazing time," the two Aquazone directors said in a joint statement.  

"Our own ambitions to grow the business and develop our product offering aligns perfectly with RSE.

"To meet the future needs of our customers and the wider markets we serve, the consolidated support of industry experts in our field is unrivalled.

"RSE have a proven track-record of scaling businesses similar to ours, investing heavily into the development of their people, whilst retaining the culture which is important to our colleagues and stakeholders.”

Aquazone, in Great YarmouthAquazone, in Great Yarmouth (Image: Supplied) RSE employs 1,800 across Scotland and England. Headquartered in Inverness, the firm also has engineering and manufacturing facilities in Leeds, Nottingham, Basingstoke and Bristol.

Steve Slessor, RSE chief executive, added: “I am delighted to welcome Chad, Alan and the Aquazone team to RSE.

"This acquisition strengthens our strategic diversification into the rental market, providing clients with flexible solutions as CAPEX [capital expenditure] budgets tighten.

"It supports our ongoing disruption of the water sector to meet the upcoming challenges of AMP8, while driving further growth in chemical and biological markets, aligning with our vision for innovation and sustainable solutions."